Telomir Pharmaceuticals Inc (TELO) saw downtrend of -2.54% in the recent trading with $1.15 being its most recent. The current price level -86.31% lower than the highest price of $8.40 marked by the stock while trading over the past 52-weeks, whereas it is -2.54% higher than the lowest price of $1.18 the company dropped to over past 52-weeks. The latest news story on TELO appeared in (ACCESSWIRE) under the title “Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria – an Ultra-Rare Genetic Disorder that Causes Rapid Aging” on Jun-18-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
Telomir Pharmaceuticals Inc Earnings – What Happened With TELO
Coming around sales and income figures on TELO Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Telomir Pharmaceuticals Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 29.76 million. TELO does have institutional investors; and they hold 12.39% of the stock.
As on 2024-06-30, BLACKROCK INC. was the top most holder in Telomir Pharmaceuticals Inc (NASDAQ:TELO) with an ownership of 87899.0 shares of the company or 0.2969 of the stake worth $0.42 million. The filing also reveals GEODE CAPITAL MANAGEMENT, LLC as the second largest holder in the company with a control over 0.2241 of the outstanding shares. Its stake is worth $0.32 million for having 66355.0 shares in hand.
BANK OF NEW YORK MELLON CORP also came holding a key position in the company during the recent quarter and it now holds 0.1694 of the outstanding shares. With this there are now 67.0 institutions which have possession in TELO’s shares.
Key Metrics forTELO
Technical Analysis of Telomir Pharmaceuticals Inc (NASDAQ:TELO) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Telomir Pharmaceuticals Inc (TELO), we notice that the stock’s 20-day average volume is at 474,710 shares and 100% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 100% are spotting the stock at Sell with its 50-day average volume of 278,940 shares. And to end, TELO’s 100-day average volume is 223,430 shares with 100% of the long-term indicators pointing towards Sell for the stock.
